Roivant Sciences LtdNASDAQ:ROIV
- LAST PRICE11.9400
- TODAY'S CHANGE (%)-0.1800 (-1.4851%)
- Bid / Lots11.9300/ 1
- Ask / Lots12.2500/ 5
- Open / Previous Close12.1500 / 12.1200
- Day Range
- 52 Week Range
- Volume6,439,517
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ROIV |
|---|---|---|
| 09:32 ET | 21167 | 12.17 |
| 09:34 ET | 21902 | 12.25 |
| 09:36 ET | 24111 | 12.245 |
| 09:38 ET | 21986 | 12.26 |
| 09:39 ET | 9783 | 12.24 |
| 09:41 ET | 18819 | 12.25 |
| 09:43 ET | 30771 | 12.25 |
| 09:45 ET | 14732 | 12.265 |
| 09:48 ET | 22206 | 12.25 |
| 09:50 ET | 12775 | 12.245 |
| 09:52 ET | 18697 | 12.25 |
| 09:54 ET | 8701 | 12.24 |
| 09:56 ET | 20200 | 12.251 |
| 09:57 ET | 43323 | 12.205 |
| 09:59 ET | 17885 | 12.205 |
| 10:01 ET | 12205 | 12.175 |
| 10:03 ET | 16336 | 12.135 |
| 10:06 ET | 14845 | 12.155 |
| 10:08 ET | 11381 | 12.14 |
| 10:10 ET | 16868 | 12.16 |
| 10:12 ET | 22004 | 12.175 |
| 10:14 ET | 8321 | 12.19 |
| 10:15 ET | 18616 | 12.18 |
| 10:17 ET | 12675 | 12.18 |
| 10:19 ET | 10087 | 12.19 |
| 10:21 ET | 36305 | 12.18 |
| 10:24 ET | 37157 | 12.21 |
| 10:26 ET | 23724 | 12.21 |
| 10:28 ET | 14176 | 12.21 |
| 10:30 ET | 41894 | 12.225 |
| 10:32 ET | 25497 | 12.19 |
| 10:33 ET | 18013 | 12.19 |
| 10:35 ET | 7783 | 12.18 |
| 10:37 ET | 31163 | 12.2 |
| 10:39 ET | 19194 | 12.205 |
| 10:42 ET | 21665 | 12.205 |
| 10:44 ET | 7923 | 12.195 |
| 10:46 ET | 8390 | 12.2 |
| 10:48 ET | 10524 | 12.165 |
| 10:50 ET | 12704 | 12.155 |
| 10:51 ET | 10039 | 12.145 |
| 10:53 ET | 23254 | 12.1002 |
| 10:55 ET | 28047 | 12.085 |
| 10:57 ET | 21886 | 12.1 |
| 11:00 ET | 16876 | 12.095 |
| 11:02 ET | 13700 | 12.1 |
| 11:04 ET | 9818 | 12.115 |
| 11:06 ET | 10259 | 12.115 |
| 11:08 ET | 15245 | 12.115 |
| 11:09 ET | 6688 | 12.095 |
| 11:11 ET | 26865 | 12.07 |
| 11:13 ET | 50158 | 12.04 |
| 11:15 ET | 14512 | 12.025 |
| 11:18 ET | 64734 | 12.06 |
| 11:20 ET | 12944 | 12.045 |
| 11:22 ET | 4694 | 12.045 |
| 11:24 ET | 26377 | 12.06 |
| 11:26 ET | 9827 | 12.07 |
| 11:27 ET | 17141 | 12.08 |
| 11:29 ET | 7391 | 12.07 |
| 11:31 ET | 6847 | 12.055 |
| 11:33 ET | 8750 | 12.065 |
| 11:36 ET | 2155 | 12.07 |
| 11:38 ET | 22382 | 12.075 |
| 11:40 ET | 16181 | 12.07 |
| 11:42 ET | 17531 | 12.09 |
| 11:44 ET | 8897 | 12.1 |
| 11:45 ET | 10421 | 12.085 |
| 11:47 ET | 3983 | 12.085 |
| 11:49 ET | 2473 | 12.09 |
| 11:51 ET | 48883 | 12.06 |
| 11:54 ET | 21912 | 12.065 |
| 11:56 ET | 25200 | 12.063 |
| 11:58 ET | 14264 | 12.045 |
| 12:00 ET | 14868 | 12.055 |
| 12:02 ET | 20379 | 12.055 |
| 12:03 ET | 4199 | 12.06 |
| 12:05 ET | 1228 | 12.055 |
| 12:07 ET | 15026 | 12.045 |
| 12:09 ET | 3453 | 12.045 |
| 12:12 ET | 15536 | 12.045 |
| 12:14 ET | 11769 | 12.06 |
| 12:16 ET | 11513 | 12.04 |
| 12:18 ET | 75663 | 12.0847 |
| 12:20 ET | 4320 | 12.08 |
| 12:21 ET | 18690 | 12.08 |
| 12:23 ET | 3982 | 12.07 |
| 12:25 ET | 24418 | 12.045 |
| 12:27 ET | 11581 | 12.0301 |
| 12:30 ET | 21727 | 12.045 |
| 12:32 ET | 11041 | 12.035 |
| 12:34 ET | 12274 | 12.02 |
| 12:36 ET | 23670 | 12.005 |
| 12:38 ET | 28034 | 11.98 |
| 12:39 ET | 13587 | 11.97 |
| 12:41 ET | 65208 | 11.97 |
| 12:43 ET | 19184 | 11.96 |
| 12:45 ET | 33509 | 11.96 |
| 12:48 ET | 27331 | 11.995 |
| 12:50 ET | 1949 | 11.9949 |
| 12:52 ET | 12039 | 11.985 |
| 12:54 ET | 5565 | 11.985 |
| 12:56 ET | 26760 | 11.99 |
| 12:57 ET | 5268 | 11.975 |
| 12:59 ET | 8435 | 11.985 |
| 01:01 ET | 55398 | 12.005 |
| 01:03 ET | 24485 | 12.02 |
| 01:06 ET | 9662 | 12.04 |
| 01:08 ET | 2811 | 12.035 |
| 01:10 ET | 8053 | 12.02 |
| 01:12 ET | 5211 | 12.02 |
| 01:14 ET | 25159 | 12.001 |
| 01:15 ET | 7796 | 12 |
| 01:17 ET | 49868 | 12.01 |
| 01:19 ET | 2446 | 12.015 |
| 01:21 ET | 1433 | 12.015 |
| 01:24 ET | 10604 | 11.995 |
| 01:26 ET | 18625 | 12.025 |
| 01:28 ET | 2782 | 12.025 |
| 01:30 ET | 9517 | 12.025 |
| 01:32 ET | 9208 | 12.015 |
| 01:33 ET | 24794 | 12.02 |
| 01:35 ET | 6713 | 12.01 |
| 01:37 ET | 3087 | 12.015 |
| 01:39 ET | 15845 | 12.02 |
| 01:42 ET | 14772 | 12.02 |
| 01:44 ET | 46633 | 12.02 |
| 01:46 ET | 9170 | 12.02 |
| 01:48 ET | 9360 | 12.02 |
| 01:50 ET | 36212 | 12.025 |
| 01:51 ET | 12289 | 12.035 |
| 01:53 ET | 15620 | 12.05 |
| 01:55 ET | 4060 | 12.055 |
| 01:57 ET | 13176 | 12.055 |
| 02:00 ET | 9439 | 12.04 |
| 02:02 ET | 19388 | 12.025 |
| 02:04 ET | 17809 | 12.04 |
| 02:06 ET | 2290 | 12.045 |
| 02:08 ET | 9482 | 12.05 |
| 02:09 ET | 32835 | 12.055 |
| 02:11 ET | 1900 | 12.06 |
| 02:13 ET | 17120 | 12.065 |
| 02:15 ET | 2601 | 12.065 |
| 02:18 ET | 9356 | 12.06 |
| 02:20 ET | 11785 | 12.075 |
| 02:22 ET | 4268 | 12.075 |
| 02:24 ET | 4616 | 12.075 |
| 02:26 ET | 17016 | 12.06 |
| 02:27 ET | 26097 | 12.06 |
| 02:29 ET | 2910 | 12.055 |
| 02:31 ET | 7800 | 12.055 |
| 02:33 ET | 5099 | 12.055 |
| 02:36 ET | 24900 | 12.08 |
| 02:38 ET | 13256 | 12.065 |
| 02:40 ET | 13477 | 12.075 |
| 02:42 ET | 4093 | 12.075 |
| 02:44 ET | 10957 | 12.085 |
| 02:45 ET | 4825 | 12.085 |
| 02:47 ET | 18466 | 12.105 |
| 02:49 ET | 25907 | 12.1 |
| 02:51 ET | 3344 | 12.095 |
| 02:54 ET | 12448 | 12.085 |
| 02:56 ET | 23027 | 12.09 |
| 02:58 ET | 32634 | 12.07 |
| 03:00 ET | 17167 | 12.055 |
| 03:02 ET | 12432 | 12.035 |
| 03:03 ET | 15751 | 12.015 |
| 03:05 ET | 2576 | 12.01 |
| 03:07 ET | 12976 | 12 |
| 03:09 ET | 5528 | 11.995 |
| 03:12 ET | 3577 | 11.99 |
| 03:14 ET | 39565 | 11.98 |
| 03:16 ET | 55021 | 12.005 |
| 03:18 ET | 72557 | 12.011 |
| 03:20 ET | 118136 | 12.015 |
| 03:21 ET | 79404 | 11.995 |
| 03:23 ET | 13289 | 12.005 |
| 03:25 ET | 2648 | 12.005 |
| 03:27 ET | 4921 | 12.006 |
| 03:30 ET | 21522 | 12 |
| 03:32 ET | 28757 | 12.015 |
| 03:34 ET | 21143 | 12 |
| 03:36 ET | 16146 | 12.015 |
| 03:38 ET | 23010 | 12.005 |
| 03:39 ET | 16767 | 11.99 |
| 03:41 ET | 10353 | 11.985 |
| 03:43 ET | 32742 | 11.98 |
| 03:45 ET | 27108 | 11.975 |
| 03:48 ET | 104349 | 11.94 |
| 03:50 ET | 64602 | 11.95 |
| 03:52 ET | 233860 | 11.945 |
| 03:54 ET | 95342 | 11.93 |
| 03:56 ET | 240931 | 11.935 |
| 03:57 ET | 98433 | 11.935 |
| 03:59 ET | 1456403 | 11.94 |
Sep 11, 2024
DJ Roivant Sciences Is Maintained at Neutral by B of A Securities, from 9:23AM ET on Wednesday Sep 11, 2024 by Dow Jones
9:23AM ET on Wednesday Sep 11, 2024 by Dow JonesDJ Roivant Sciences Price Target Maintained With a $18.00/Share by HC Wainwright & Co., from 6:43AM ET on Wednesday Sep 11, 2024 by Dow Jones
6:43AM ET on Wednesday Sep 11, 2024 by Dow Jones
Sep 10, 2024
Pulmovant presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat in Pulmonary Hypertension at European Respiratory Society Congress, from 6:30AM ET on Tuesday Sep 10, 2024 by Dow Jones
6:30AM ET on Tuesday Sep 10, 2024 by Dow JonesRoivant Unveils New Pipeline Program Mosliciguat, A Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator, from 6:30AM ET on Tuesday Sep 10, 2024 by Dow Jones
6:30AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 9, 2024
Roivant Provides Update on Graves' Disease Development Program, from 7:00AM ET on Monday Sep 09, 2024 by Dow Jones
7:00AM ET on Monday Sep 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Roivant Sciences Ltd | 8.8B | 2.1x | --- |
Ligand Pharmaceuticals Inc | 1.9B | 47.1x | -12.71% |
Corcept Therapeutics Inc | 4.0B | 33.5x | +9.80% |
Harrow Inc | 1.6B | -47.5x | --- |
Ocular Therapeutix Inc | 1.4B | -8.2x | --- |
Immunocore Holdings PLC | 1.7B | -31.3x | --- |
Company Information
Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline includes VTAMA, a novel topical approved for the treatment of psoriasis and in development for the treatment of atopic dermatitis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting the neonatal Fc receptor (FcRn) in development across several IgG-mediated autoimmune indications; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 for the treatment of dermatomyositis and non-infectious uveitis, in addition to other clinical-stage molecules. It advances its pipeline by creating nimble subsidiaries or Vants to develop and commercialize its medicines and technologies. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its pipeline program also includes Mosliciguat.
Contact Information
- Headquarters
- 11-12 St. James's Square Suite 1, 3rd FloorLONDON, United Kingdom SW1Y4LB
- Phone
- 207-400-3347
- Fax
- ---
Executives
- Independent Chairman of the Board
- Ilan Oren
- President, Chief Operating Officer
- Eric Venker
- President, Chief Investment Officer, Director
- Mayukh Sukhatme
- Chief Executive Officer, Director
- Matthew Gline
- Chief Financial Officer
- Richard Pulik
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.8B |
|---|---|
Revenue (TTM) | $158.3M |
Shares Outstanding | 739.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $5.57 |
Book Value | $7.40 |
P/E Ratio | 2.1x |
Price/Sales (TTM) | 55.8 |
Price/Cash Flow (TTM) | 1.9x |
Operating Margin | 2,799.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
